Commentary: Orbital Atherectomy in Perspective

Abstract

Keywords

balloon angioplasty amputation atherectomy in-stent restenosis orbital atherectomy office-based vascular laboratory outpatient setting peripheral artery disease stent

Get full access to this article

View all access options for this article.

References

Giannopoulos

Secemsky

Mustapha

, et al. Three-year outcomes of orbital atherectomy for the endovascular treatment of infrainguinal claudication or chronic limb-threatening ischemia. J Endovasc Ther. 2020;27(5):714–725.

Gerhard-Herman

Gornik

Barrett

, et al. 2016 AHA/ACC guideline on the management of patients with lower extremity peripheral artery disease: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. J Am Coll Cardiol. 2017;69:1465–1508.

The Food and Drug Administration (FDA) announcement. Circulatory System Devices Panel of the Medical Devices Advisory Committee Meeting. June 19-20, 2019. https://www.fda.gov/advisory-committees/advisory-committee-calendar/june-19-20-2019-circulatory-system-devices-panel-medical-devices-advisory-committee-meeting . Accessed July 5, 2020.

The Food and Drug Administration Update: Treatment of peripheral arterial disease with paclitaxel-coated balloons and paclitaxel-eluting stents potentially associated with increased mortality. August 7, 2019. https://www.fda.gov/medical-devices/letters-health-care-providers/august-7-2019-update-treatment-peripheral-arterial-disease-paclitaxel-coated-balloons-and-paclitaxel . Accessed July 5, 2020.

Katsanos

Spiliopoulos

Kitrou

, et al. Risk of death following application of paclitaxel-coated balloons and stents in the femoropopliteal artery of the leg: a systematic review and meta-analysis of randomized controlled trials. J Am Heart Assoc. 2018;7:e011245.

Lai

Roush

Fenlon

, et al. Outcomes of atherectomy for lower extremity ischemia in an office endovascular center. J Vasc Surg. 2020;71:1276–1285.

D’Souza

Stout

Krol

, et al. Outpatient endovascular tibial artery intervention in an office-based setting is as safe and effective as in a hospital setting. J Endovasc Ther. 2018;25:666–672.